Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX

Financials ($)
Sales 2015 3,10 M
EBIT 2015 -123 M
Net income 2015 -128 M
Debt 2015 190 M
Yield 2015 -
Sales 2016 14,0 M
EBIT 2016 -141 M
Net income 2016 -166 M
Debt 2016 39,0 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 458x
EV / Sales 2016 90,5x
Capitalization 1 230 M
More Financials
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
09/29 LEXICON PHARMACEUTICALS : Telotristat Etiprate Shows Clinical benefit in Treatin..
09/17 LEXICON PHARMACEUTICALS : Announces Sotagliflozin Data To Be Presented At Europe..
09/02 LEXICON PHARMACEUTICALS : Announces Telotristat Etiprate Data To Be Presented At..
08/26 LEXICON PHARMACEUTICALS : to Report Second Quarter 2015 Financial Results on Aug..
08/20 LEXICON PHARMACEUTICALS : To Present At The 2015 Wedbush PacGrow Healthcare Conf..
08/12 LEXICON PHARMACEUTICALS : to Report Second Quarter 2015 Financial Results on Aug..
08/12 LEXICON PHARMACEUTICALS : Reports Positive Top-Line Results For Pivotal Phase 3 ..
08/12 LEXICON PHARMACEUTICALS : to Present at the 2015 Wedbush PacGrow Healthcare Conf..
More news
Sector news : Bio Therapeutic Drugs
06:24p ALKERMES : FDA Approves ARISTADA™ for Treatment of Schizophrenia
04:55p Pacific trade deal adds to U.S. price quandary for biotech drugs
04:04p QIAGEN NV : launches new bioinformatics solution for hereditary diseases
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/01 SEEKING ALPHA'S BIOTECH WEEKLY : A Gilead Victory, Celladon Crumbles, And More
05/01 Lexicon Undervalued As It Approaches A Major Event
04/29 Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2015 Results - Earning..
04/29 Lexicon Pharmaceuticals EPS in-line, beats on revenue
03/20 Lexicon Pharmaceuticals - A Diamond In The Rough?
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Technical analysis trends LEXICON PHARMACEU...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions